A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects

NCT04135898 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male

Interventions

DRUG: SIBP-04
DRUG: Bevacizumab

Sponsor

Shanghai Institute Of Biological Products